支原体
抗细菌
结核分枝杆菌
微生物学
最小抑制浓度
药品
肺结核
抗药性
分枝杆菌
化学
药理学
生物
抗菌剂
医学
病理
作者
Gamal A. I. Moustafa,Shoji Nojima,Yasushi Yamano,Akio Ando,Masayoshi Arai,Satoshi Mitarai,Tetsuaki Tanaka,Takehiko Yoshimitsu
出处
期刊:MedChemComm
[The Royal Society of Chemistry]
日期:2013-01-01
卷期号:4 (4): 720-720
被引量:16
摘要
The potent antimycobacterial activity of (±)-platencin is reported. Complete inhibition of Mycobacterium smegmatis growth was observed at MICs of 0.5 μg mL−1 and 0.3 μg mL−1 under aerobic and hypoxic conditions, respectively. Notably, the compound exhibited potent bacteriostatic activities towards Mycobacterium tuberculosis H37Rv (MIC = 2 μg mL−1), multi-drug-resistant M. tuberculosis (MIC = 1 μg mL−1), and extensively drug-resistant M. tuberculosis (MIC = 1 μg mL−1). An overexpression study of the transformants of M. smegmatis revealed that platencin selectively targeted Mt-KasB and modestly inhibited Mt-KasA and Mt-FabH.
科研通智能强力驱动
Strongly Powered by AbleSci AI